Recurrent lung non-small cell carcinoma

Clinical trials for Recurrent lung non-small cell carcinoma explained in plain language.

Never miss a new study

Get alerted when new Recurrent lung non-small cell carcinoma trials appear

Sign up with your email to follow new studies for Recurrent lung non-small cell carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 12 Not yet recruiting 1 Not yet finished but already full! 22 Completed 4 Terminated 1

Targeted drug poziotinib tested in rare lung cancer mutations

Disease control Stopped early

This phase II trial tested the drug poziotinib in 93 people with advanced non-small cell lung cancer that has specific changes in the EGFR or HER2 genes. The goal was to see if the drug could shrink tumors or stop them from growing. The study was terminated early, so results are …

Matched conditions: RECURRENT LUNG NON-SMALL CELL CARCINOMA

Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 09:07 UTC

Recurrent lung non-small cell carcinoma

Get alerted when new Recurrent lung non-small cell carcinoma trials appear

Targeted drug poziotinib tested in rare lung cancer mutations